ASPN
Aspen Aerogels, Inc.
ASPN has a slight edge over BA overall, supported by stronger modeled upside.
BA
The Boeing Company
BA has lower modeled downside risk, despite its lower overall score.
ASPN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Under pressure | |
| Healthy | |
| Strong |
ASPN's cash flow and balance sheet are currently healthy, but its revenue and profitability are under pressure.
BA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
ASPN PE Valuation
ASPN has no meaningful PE right now: it lost money over the past year.
BA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $172 | — |
| Cheap | 51x | $496 | +189% |
| Fair | 82x | $790 | +360% |
| Expensive | 91x | $876 | +411% |
Historical ranges are pointers, not guarantees.
BA's PE is 18x, but its earnings don't support one, so it isn't a reliable read right now.
ASPN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect ASPN's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
BA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect BA to return to profit, with revenue growing. However, they disagree widely on these estimates.
ASPN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$1.57 | +$2.14 |
| Q2 2026 | -$1.52 | +$2.28 |
| Q1 2026 | -$1.35 | +$2.13 |
| Q4 2025 | -$4.73 | -2882% |
| Q3 2025 | -$3.71 | -37200% |
| Q2 2025 | -$3.80 | -$3.79 |
| Q1 2025 | -$3.48 | -$3.04 |
| Q4 2024 | $0.17 | +$0.83 |
ASPN lost $1.57 per share over the past year, a smaller loss than the year before.
BA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $9.66 | +$23.38 |
| Q2 2026 | $2.78 | +$19.33 |
| Q1 2026 | $2.53 | +$20.49 |
| Q4 2025 | $2.48 | +$20.84 |
| Q3 2025 | -$13.72 | -$0.83 |
| Q2 2025 | -$16.55 | -$10.93 |
| Q1 2025 | -$17.96 | -$14.42 |
| Q4 2024 | -$18.36 | -$14.69 |
BA has the edge over ASPN on earnings quality, reporting a profit while its opponent remains loss making.
ASPN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $85.2M | +17% |
| Q2 2026 | $49.8M | -36% |
| Q1 2026 | $37.9M | -52% |
| Q4 2025 | $41.3M | -66% |
| Q3 2025 | $73M | -38% |
| Q2 2025 | $78M | -34% |
| Q1 2025 | $78.7M | -17% |
| Q4 2024 | $123.1M | +46% |
ASPN's revenue is recovering but still below its 2024 peak: $85M last quarter, up 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -8.4% | -3.8 points |
| Q2 2026 | -58% | -51 points |
| Q1 2026 | -55% | +325 points |
| Q4 2025 | -170% | -182 points |
| Q3 2025 | -4.6% | -19 points |
| Q2 2025 | -6.6% | -24 points |
| Q1 2025 | -380% | -383 points |
| Q4 2024 | 12% | +10 points |
ASPN's operating margin was −8.4% last quarter, down 3.8 points from the same quarter a year ago.
BA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.2B | +3.9% |
| Q2 2026 | $24.6B | +8% |
| Q1 2026 | $22.2B | +14% |
| Q4 2025 | $23.9B | +57% |
| Q3 2025 | $23.3B | +30% |
| Q2 2025 | $22.7B | +35% |
| Q1 2025 | $19.5B | +18% |
| Q4 2024 | $15.2B | -31% |
BA has the edge over ASPN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +22 points |
| Q2 2026 | 0.6% | +1.4 points |
| Q1 2026 | 2% | -0.3 points |
| Q4 2025 | 37% | +61 points |
| Q3 2025 | -21% | +12 points |
| Q2 2025 | -0.8% | +5.7 points |
| Q1 2025 | 2.4% | +2.9 points |
| Q4 2024 | -25% | -26 points |
BA has the edge over ASPN on profitability, with a higher operating margin.
ASPN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$8.5M | -243% |
| Q2 2026 | -$18M | -$1.2M |
| Q1 2026 | $32.8M | +$40.1M |
| Q4 2025 | $13.7M | -35% |
| Q3 2025 | $5.9M | +$6M |
| Q2 2025 | -$16.8M | +$1.2M |
| Q1 2025 | -$7.4M | +$36.2M |
| Q4 2024 | $20.9M | +$51.5M |
ASPN has burned cash in most quarters: $20M over the past year, about seven times what it generated the year before.
BA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $464M | +95% |
| Q2 2026 | $631M | +$831M |
| Q1 2026 | -$1.5B | +$836M |
| Q4 2025 | $375M | +$4.5B |
| Q3 2025 | $238M | +$2.2B |
| Q2 2025 | -$200M | +$4.1B |
| Q1 2025 | -$2.3B | +$1.6B |
| Q4 2024 | -$4.1B | -239% |
BA has the edge over ASPN on cash flow, with more consistent year-over-year improvement.
ASPN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +178K shares |
| 1 year | +0.8% | +670K shares |
| 3 years | +20% | +13.8M shares |
| 5 years | +191% | +54.6M shares |
| Available history | +245% | +59M shares |
ASPN has the edge over BA on shareholder dilution, with a more favorable share count trend.
BA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +2.1M shares |
| 1 year | +4.3% | +32.8M shares |
| 3 years | +31% | +186M shares |
| 5 years | +35% | +204M shares |
| Available history | +40% | +227M shares |
BA has 793M diluted shares, up 4.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
ASPN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2024 | -1.6x | Net Cash |
| Q3 2024 | -0.3x | Net Cash |
| Q2 2024 | -3.0x | Net Cash |
ASPN has more cash than debt.
BA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 6.0x | High |
| Q4 2025 | 6.9x | High |
| Q2 2024 | 361.8x | High |
| Q1 2024 | 36.1x | High |
| Q4 2023 | 36.4x | High |
| Q3 2023 | 96.1x | High |
BA's net debt is about 3.0 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
ASPN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.7 | Neutral |
| Stochastic | 33.1 | Neutral |
ASPN's weekly RSI is 58 (neutral) and its Stochastic is 33 (neutral).
BA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.1 | Neutral |
| Stochastic | 9.6 | Oversold |
BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).
ASPN PE vs Industrials Sector
| Metric | ASPN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 24x | — |
ASPN has no meaningful PE right now: it lost money over the past year.
BA PE vs Industrials Sector
| Metric | BA | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 26% below |
| PE % | 0 | 58 | 58 pts below |
BA is trading at 18x earnings, a 26% discount to the Industrials sector's median of 24x, though its earnings don't support one.
ASPN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $5.40 | 11% above |
| 20 week MA | $5.28 | 13% above |
| 50 week MA | $4.53 | 32% above |
| 100 week MA | $5.97 | 0.3% above |
| 200 week MA | $10.3 | 42% below |
ASPN has the edge over BA on trend strength, trading above more of its moving averages.
BA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $184.6 | 7.1% below |
| 20 week MA | $203.8 | 16% below |
| 50 week MA | $215.5 | 20% below |
| 100 week MA | $205.9 | 17% below |
| 200 week MA | $200.6 | 14% below |
BA is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.
ASPN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $7.74 | $17.7 | +129% |
| 2021 | $17.7 | $50.8 | +187% |
| 2022 | $50.8 | $11.6 | -77% |
| 2023 | $11.6 | $15.8 | +36% |
| 2024 | $15.8 | $12.5 | -21% |
| 2025 | $12.5 | $2.94 | -76% |
| 2026 YTD | $2.94 | $5.99 | +104% |
ASPN has the edge over BA on returns for 2026, with the stronger performance.
BA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $330.1 | $217.2 | -34% |
| 2021 | $217.2 | $204.2 | -6% |
| 2022 | $204.2 | $189.1 | -7.4% |
| 2023 | $189.1 | $260.7 | +38% |
| 2024 | $260.7 | $180.7 | -31% |
| 2025 | $180.7 | $216.4 | +20% |
| 2026 YTD | $216.4 | $171.6 | -21% |
BA has finished lower in four of the last six years. It's down 21% so far in 2026.